pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

New studies highlight hurdles in lowering blood pressure after stroke or in diabetes patients

Nov 7, 2026·read at STAT ↗Negative readoutNeutral

Researchers presented three new studies at the American Heart Association scientific sessions that examined how to lower blood pressure in patients who have had a stroke or who live with type 2 diabetes. The work underscores the difficulty of achieving safe blood pressure targets in these high‑risk groups.

One small, diverse trial tested a common diuretic in post‑stroke patients, another explored more intensive therapy to reach lower‑than‑standard blood pressure goals after stroke, and a third investigated the effects of tighter blood pressure control in people with type 2 diabetes.

Scientists and clinicians at a media briefing emphasized that while the drugs are widely available, translating tighter blood pressure goals into practice remains challenging. The findings suggest that more coordinated, cross‑specialty approaches are needed to improve outcomes for these vulnerable patients.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Lowering blood pressure after stroke or with diabetes poses challenges, in research and practice”

read at STAT ↗
1,167 words · retrieved 24m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 5h agoSTAT+: BIO joins the legal fight against Medicare pilot that ties drug prices to peer countriesSTAT
  • 7h agoSTAT+: Failure of Novartis Lp(a) drug raises questions about cardiovascular strategySTAT
  • 8h agoSTAT+: Despite Novo drug’s failure, cardiologists say they will still pursue anti-inflammatoriesSTAT
  • 1d agoSTAT+: States sue Trump administration again to delay Medicaid work requirementsSTAT
  • 1d agoSTAT+: MAHA leader Calley Means castigates White House officials as bending to industrySTAT